Alembic Pharma Receives USFDA Approval for Generic Blood Cancer Drug

A company called Alembic Pharmaceuticals has gotten permission from the US government to sell a new version of a medicine.

This medicine is used to help people who have certain kinds of blood cancer, like leukemia.

It's a copycat version of another medicine that already exists, so it's called a generic.

Getting this permission means they can now sell it in the United States.

The medicine comes in different strengths.

It can be used for adults and also for children who are at least one year old.

This new generic medicine has a big market, with people spending over a billion dollars on the original medicine in a recent year.